Axon Enterprise, Inc $AXON Stock Holdings Raised by SteelPeak Wealth LLC

SteelPeak Wealth LLC boosted its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 35,664.2% in the third quarter, HoldingsChannel reports. The firm owned 238,547 shares of the biotechnology company’s stock after buying an additional 237,880 shares during the period. Axon Enterprise makes up about 2.5% of SteelPeak Wealth LLC’s portfolio, making the stock its 7th largest position. SteelPeak Wealth LLC’s holdings in Axon Enterprise were worth $100,791,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Keating Financial Advisory Services Inc. acquired a new position in shares of Axon Enterprise during the second quarter valued at about $31,000. Wealth Enhancement Trust Services Inc. bought a new position in shares of Axon Enterprise during the 3rd quarter worth about $33,000. Washington Trust Advisors Inc. boosted its position in shares of Axon Enterprise by 1,300.0% during the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after purchasing an additional 65 shares in the last quarter. Delos Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the 2nd quarter worth about $45,000. Finally, Owl Creek Wealth Partners LLC grew its stake in shares of Axon Enterprise by 84.8% in the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 39 shares during the period. 79.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of research analyst reports. Barclays boosted their target price on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 5th. Citigroup reiterated a “market outperform” rating on shares of Axon Enterprise in a report on Thursday, September 17th. TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a research note on Tuesday. Finally, Morgan Stanley raised their price objective on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $718.47.

Axon Enterprise Stock Down 6.4%

Axon Enterprise stock opened at $390.29 on Friday. The firm has a market capitalization of $31.71 billion, a price-to-earnings ratio of 161.95, a price-to-earnings-growth ratio of 7.34 and a beta of 1.44. The firm’s fifty day moving average price is $501.59 and its two-hundred day moving average price is $474.43. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $764.02. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm’s revenue for the quarter was up 35.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.12 earnings per share. On average, equities research analysts predict that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. The trade was a 0.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president directly owned 296,974 shares of the company’s stock, valued at $170,590,774.82. This represents a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 47,397 shares of company stock worth $26,722,984 in the last quarter. 4.20% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.